STEREOTAXIS INC (STXS)
US85916J4094 - Common Stock
We assign a fundamental rating of 2 out of 10 to STXS. STXS was compared to 192 industry peers in the Health Care Equipment & Supplies industry. STXS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, STXS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year STXS has reported negative net income.
STXS had a negative operating cash flow in the past year.
STXS had negative earnings in each of the past 5 years.
In the past 5 years STXS always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -52.64%, STXS is doing worse than 70.31% of the companies in the same industry.
With a Return On Equity value of -100.63%, STXS is not doing good in the industry: 69.79% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.64% | ||
| ROE | -100.63% | ||
| ROIC | N/A |
ROA(3y)-36.39%
ROA(5y)-27.49%
ROE(3y)-64.24%
ROE(5y)-46.75%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
STXS has a Gross Margin of 55.53%. This is comparable to the rest of the industry: STXS outperforms 51.04% of its industry peers.
STXS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for STXS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.98%
GM growth 5Y-7.17%
2. Health
2.1 Basic Checks
STXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for STXS has been increased compared to 1 year ago.
STXS has more shares outstanding than it did 5 years ago.
STXS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -12.80, we must say that STXS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -12.80, STXS is not doing good in the industry: 82.81% of the companies in the same industry are doing better.
STXS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -12.8 |
ROIC/WACCN/A
WACC10.06%
2.3 Liquidity
STXS has a Current Ratio of 2.51. This indicates that STXS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of STXS (2.51) is worse than 63.02% of its industry peers.
STXS has a Quick Ratio of 1.88. This is a normal value and indicates that STXS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.88, STXS is not doing good in the industry: 60.94% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.88 |
3. Growth
3.1 Past
The earnings per share for STXS have decreased by -7.69% in the last year.
The Revenue has decreased by -4.88% in the past year.
Measured over the past years, STXS shows a decrease in Revenue. The Revenue has been decreasing by -1.82% on average per year.
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-16.67%
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y0.18%
Revenue growth 5Y-1.82%
Revenue growth Q2Q-37.47%
3.2 Future
Based on estimates for the next years, STXS will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.27% on average per year.
The Revenue is expected to grow by 33.01% on average over the next years. This is a very strong growth
EPS Next Y16.94%
EPS Next 2Y16.88%
EPS Next 3Y19.27%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y20.67%
Revenue Next 3Y33.01%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
STXS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STXS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as STXS's earnings are expected to grow with 19.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.88%
EPS Next 3Y19.27%
5. Dividend
5.1 Amount
No dividends for STXS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
STEREOTAXIS INC
NYSEARCA:STXS (4/30/2024, 9:29:06 AM)
2.29
-0.01 (-0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap188.08M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.64% | ||
| ROE | -100.63% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.53% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.88 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y16.94%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y0.18%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y